[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

June 2019 - July 1959




August 2018, Vol 75, No. 8, Pages 765-867

In This Issue of JAMA Psychiatry


Abstract Full Text
free access
JAMA Psychiatry. 2018;75(8):765. doi:10.1001/jamapsychiatry.2017.2992

Making the Opioid Public Health Emergency Effective

Abstract Full Text
JAMA Psychiatry. 2018;75(8):767-768. doi:10.1001/jamapsychiatry.2018.0611

This Viewpoint discusses steps to implement to effectively address the opioid public health emergency.

On the Marketing and Use of Pharmacogenetic Tests for Psychiatric Treatment

Abstract Full Text
JAMA Psychiatry. 2018;75(8):769-770. doi:10.1001/jamapsychiatry.2018.0834

This Viewpoint discusses issues associated with the use of pharmacogenetic tests to guide treatment in patients with major depressive disorder.


The Urgent Need for Optimal Monitoring of Metabolic Adverse Effects in Children and Youngsters Who Take On-label or Off-label Antipsychotic Medication

Abstract Full Text
JAMA Psychiatry. 2018;75(8):771-772. doi:10.1001/jamapsychiatry.2018.1080

Motivational Impairments in Autism May Be Broader Than Previously Thought

Abstract Full Text
JAMA Psychiatry. 2018;75(8):773-774. doi:10.1001/jamapsychiatry.2018.1078

More Evidence That Abortion Is Not Associated With Increased Risk of Mental Illness

Abstract Full Text
JAMA Psychiatry. 2018;75(8):775-776. doi:10.1001/jamapsychiatry.2018.0838
Original Investigation

Efficacy of Dialectical Behavior Therapy for Adolescents at High Risk for Suicide: A Randomized Clinical Trial

Abstract Full Text
has active quiz
JAMA Psychiatry. 2018;75(8):777-785. doi:10.1001/jamapsychiatry.2018.1109

This randomized clinical trial evaluates the efficacy of dialectical behavior therapy compared with individual and group supportive therapy for reducing suicide attempts, nonsuicidal self-injury, and overall self-harm among high-risk youths.

Metabolic Effects of Antipsychotics on Adiposity and Insulin Sensitivity in Youths: A Randomized Clinical Trial

Abstract Full Text
JAMA Psychiatry. 2018;75(8):788-796. doi:10.1001/jamapsychiatry.2018.1088

This randomized clinical trial characterizes the metabolic effects of first exposure to antipsychotics in youths with disruptive behavior disorders using criterion standard assessments of body composition and tissue-specific insulin sensitivity.

Evaluation of the Social Motivation Hypothesis of Autism: A Systematic Review and Meta-analysis

Abstract Full Text
JAMA Psychiatry. 2018;75(8):797-808. doi:10.1001/jamapsychiatry.2018.1100

This systematic review and meta-analysis examines brain activation response to rewards in individuals with autism spectrum disorder compared with typically developing individuals.

Association of Hypertensive Disorders of Pregnancy With Risk of Neurodevelopmental Disorders in Offspring: A Systematic Review and Meta-analysis

Abstract Full Text
JAMA Psychiatry. 2018;75(8):809-819. doi:10.1001/jamapsychiatry.2018.0854

This systemic review and meta-analysis examines the association between hypertensive disorders of pregnancy and risk of neurodevelopmental disorders in offspring.

Causes of Death After Nonfatal Opioid Overdose

Abstract Full Text
JAMA Psychiatry. 2018;75(8):820-827. doi:10.1001/jamapsychiatry.2018.1471

This national longitudinal cohort study of US adults who had experienced a nonfatal opioid overdose determines rates of all-cause and cause-specific mortality and standardized mortality rate ratios in the first year after the overdose.

Examining the Association of Antidepressant Prescriptions With First Abortion and First Childbirth

Abstract Full Text
JAMA Psychiatry. 2018;75(8):828-834. doi:10.1001/jamapsychiatry.2018.0849

This study of a large cohort of Danish women examines the association between first-trimester first abortion or first childbirth with risk of a first-time prescription for an antidepressant.

Association of Autistic Traits With Depression From Childhood to Age 18 Years

Abstract Full Text
open access
JAMA Psychiatry. 2018;75(8):835-843. doi:10.1001/jamapsychiatry.2018.1323

This longitudinal study compares trajectories of depressive symptoms from ages 10 to 18 years for children with or without autism spectrum disorders and autistic traits and explores the role of genetic confounding and environmental intermediaries such as bullying.

Assessment of Neurocognitive Functions in 7-Year-Old Children at Familial High Risk for Schizophrenia or Bipolar Disorder: The Danish High Risk and Resilience Study VIA 7

Abstract Full Text
JAMA Psychiatry. 2018;75(8):844-852. doi:10.1001/jamapsychiatry.2018.1415

This population-based cohort study characterizes neurocognitive functions in 7-year-old children at familial high risk of schizophrenia and bipolar disorder in the Danish High Risk and Resilience Study VIA 7.

Assessment of the Prodromal Questionnaire–Brief Child Version for Measurement of Self-reported Psychoticlike Experiences in Childhood

Abstract Full Text
JAMA Psychiatry. 2018;75(8):853-861. doi:10.1001/jamapsychiatry.2018.1334

This population-based longitudinal study examined the construct validity and psychometric properties of a measure of psychoticlike symptoms, the Prodromal Questionnaire–Brief Child Version, among children enrolled in the first wave of the Adolescent Brain and Cognitive Development study.

Invited Commentary

Dialectical Behavior Therapy—A Highly Effective Treatment for Some Adolescents Who Self-harm

Abstract Full Text
JAMA Psychiatry. 2018;75(8):786-787. doi:10.1001/jamapsychiatry.2018.1079
Research Letter

Risk of Heroin Dependence in Newly Incident Heroin Users

Abstract Full Text
JAMA Psychiatry. 2018;75(8):863-864. doi:10.1001/jamapsychiatry.2018.1214

This study assesses data from the 2002 to 2016 US National Survey on Drug Use and Health data sets to determine the percentage of newly incident heroin users who became heroin dependent.

Association of Cannabis Use With Adolescent Psychotic Symptoms

Abstract Full Text
JAMA Psychiatry. 2018;75(8):864-866. doi:10.1001/jamapsychiatry.2018.1330

This cohort study investigates year-to-year associations between cannabis use and psychosis over 4 years in youth aged 13 to 16 years.


Incomplete Author Name Indexed

Abstract Full Text
free access
JAMA Psychiatry. 2018;75(8):866. doi:10.1001/jamapsychiatry.2018.1565

Omission of Grant Number

Abstract Full Text
free access
JAMA Psychiatry. 2018;75(8):867. doi:10.1001/jamapsychiatry.2018.2102

Changes to Conflict of Interest Disclosures

Abstract Full Text
free access
JAMA Psychiatry. 2018;75(8):867. doi:10.1001/jamapsychiatry.2018.2137
JAMA Psychiatry Masthead

JAMA Psychiatry

Abstract Full Text
free access
JAMA Psychiatry. 2018;75(8):766. doi:10.1001/jamapsychiatry.2017.2993